ArticleEndocrine connections2026
Mapping transition of care for rare endocrine conditions: findings from a cross-sectional survey by the Endo-ERN ToC Working Group.
Article in Endocrine connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adolescents and young adults with rare endocrine conditions face significant challenges during the transition from paediatric to adult healthcare systems. Despite increasing awareness, unstructured transitional care is frequent across Europe and is linked to adverse health outcomes, reduced adherence, and loss to follow-up. Objective: This study aimed to map existing models of care and identify key barriers and needs that could inform the development of standardised tools and recommendations to support improved transition processes within the European Reference Network on Rare Endocrine Conditions (Endo-ERN) framework. Methods: A cross-sectional, web-based survey was developed and disseminated by the 'Transition of Care' Working Group. The questionnaire comprised 31 items across 10 thematic domains and targeted both Endo-ERN and non-affiliated centres. Responses were collected between January and March 2025. Statistical and qualitative thematic analyses were performed. Results: A total of 111 responses were analysed from 80 centres across 21 European countries. Findings revealed marked heterogeneity in transition models, use of protocols, and availability of psychological support. Only about half of the centres reported shared paediatric-adult visits, and over one-third lacked follow-up strategies. E-health tools were underutilised despite expressed interest. A significant proportion of participants reported limited access to transition coordinators and heterogeneous privacy and data protection practices, highlighting concerns regarding General Data Protection Regulation (GDPR) compliance. Conclusion: The study underscores the need for standardised, patient-centred models of transitional care for rare endocrine conditions across Europe. Findings will inform the creation of harmonised tools and protocols to guide multidisciplinary collaboration and improve long-term outcomes. Plain language summary: Young people with rare endocrine conditions often struggle when moving from child to adult healthcare. We surveyed centres across Europe and found large differences in how this process is organised. Our findings highlight the need for clearer plans, better coordination, and tools to support a safer and more consistent transition for all patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.